BSE Live
Dec 12, 16:01Prev. Close
3801.20
Open Price
3751.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 12, 15:52Prev. Close
3799.00
Open Price
3801.50
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
3791.50 (172)
| Balance Sheet of Torrent Pharmaceuticals (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 84.62 | 84.62 | 84.62 | 84.62 | 84.62 | |
| Total Share Capital | 84.62 | 84.62 | 84.62 | 84.62 | 84.62 | |
| Reserves and Surplus | 5,036.35 | 4,930.65 | 4,471.87 | 4,369.09 | 3,622.69 | |
| Total Reserves and Surplus | 5,036.35 | 4,930.65 | 4,471.87 | 4,369.09 | 3,622.69 | |
| Total Shareholders Funds | 5,120.97 | 5,015.27 | 4,556.49 | 4,453.71 | 3,707.31 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 3,124.45 | 3,739.99 | 4,111.46 | 2,208.74 | 1,784.27 | |
| Deferred Tax Liabilities [Net] | 0.00 | 7.51 | 0.00 | 100.73 | 171.30 | |
| Other Long Term Liabilities | 74.85 | 12.91 | 15.47 | 6.88 | 9.02 | |
| Long Term Provisions | 176.72 | 163.77 | 149.10 | 126.34 | 114.69 | |
| Total Non-Current Liabilities | 3,376.02 | 3,924.18 | 4,276.03 | 2,442.69 | 2,079.28 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 789.31 | 726.60 | 1,040.20 | 0.00 | 0.00 | |
| Trade Payables | 682.07 | 582.33 | 775.72 | 547.95 | 665.17 | |
| Other Current Liabilities | 1,822.33 | 1,694.82 | 1,091.57 | 551.16 | 789.83 | |
| Short Term Provisions | 93.77 | 84.07 | 80.06 | 55.40 | 46.95 | |
| Total Current Liabilities | 3,387.48 | 3,087.82 | 2,987.55 | 1,154.51 | 1,501.95 | |
| Total Capital And Liabilities | 11,884.47 | 12,027.27 | 11,820.07 | 8,050.91 | 7,288.54 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 2,813.15 | 2,673.30 | 2,299.28 | 1,832.87 | 943.76 | |
| Intangible Assets | 4,384.35 | 4,751.85 | 5,129.25 | 1,690.62 | 1,737.63 | |
| Capital Work-In-Progress | 513.33 | 470.88 | 422.77 | 462.44 | 983.69 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 7,733.91 | 7,922.73 | 7,875.91 | 3,996.56 | 3,665.08 | |
| Non-Current Investments | 134.87 | 134.87 | 149.83 | 148.41 | 153.91 | |
| Deferred Tax Assets [Net] | 67.76 | 0.00 | 0.82 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 2.29 | 2.61 | 2.48 | 108.82 | 151.71 | |
| Other Non-Current Assets | 126.38 | 218.11 | 151.89 | 251.54 | 180.04 | |
| Total Non-Current Assets | 8,065.21 | 8,278.32 | 8,180.93 | 4,505.33 | 4,150.74 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.02 | 351.35 | 475.22 | 787.43 | 764.24 | |
| Inventories | 1,507.76 | 1,358.30 | 1,299.40 | 1,032.29 | 970.13 | |
| Trade Receivables | 1,508.94 | 1,356.01 | 1,108.04 | 1,018.47 | 911.50 | |
| Cash And Cash Equivalents | 390.95 | 237.84 | 57.12 | 78.22 | 82.37 | |
| Short Term Loans And Advances | 3.64 | 3.79 | 110.12 | 42.69 | 40.19 | |
| OtherCurrentAssets | 407.95 | 441.66 | 589.24 | 586.48 | 369.37 | |
| Total Current Assets | 3,819.26 | 3,748.95 | 3,639.05 | 3,545.49 | 3,136.98 | |
| Total Assets | 11,884.47 | 12,027.27 | 11,820.07 | 8,050.91 | 7,288.54 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 325.37 | 374.94 | 313.53 | 394.39 | 342.97 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 606.54 | 552.15 | 359.99 | 530.41 | 364.97 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | 2,918.54 | |
| Other Earnings | 2,079.25 | 2,210.26 | 1,458.01 | 2,006.64 | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 77.80 | 77.80 | 77.80 | 77.80 | 77.80 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 134.87 | 134.87 | 149.83 | 148.41 | 153.91 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | 764.23 | |
| Current Investments Unquoted Book Value | -- | 351.35 | 475.22 | 787.43 | -- |
14.11.2025
Torrent Pharma Consolidated September 2025 Net Sales at Rs 3,302.00 crore, up 14.3% Y-o-Y
12.11.2025
Torrent Pharma Standalone September 2025 Net Sales at Rs 2,762.00 crore, up 13.48% Y-o-Y
29.07.2025
Torrent Pharma Consolidated June 2025 Net Sales at Rs 3,178.00 crore, up 11.16% Y-o-Y
29.07.2025
Torrent Pharma Standalone June 2025 Net Sales at Rs 2,616.00 crore, up 7.3% Y-o-Y
12.07.2023
Torrent Pharma Q1 PAT may dip 9.7% YoY to Rs 319.7 cr: Nirmal Bang
17.01.2023
Torrent Pharma Q3 PAT seen up 28.9% YoY to Rs 3,211 cr: Nirmal Bang
13.07.2022
Torrent Pharma Q1 PAT seen up 2.8% YoY to Rs 339.1 cr: ICICI Direct
08.07.2022
Torrent Pharmaceuticals Q1 PAT seen up 1.4% YoY to Rs 334.5 cr: Prabhudas Lilladher
24.07.2019
Torrent Pharma shares jump 6% as brokerages remain bullish after Q1 show
25.08.2018
Pharma Q1 review: Brokerages say performance a mixed bag, but are upbeat on domestic biz
22.01.2014
14.01.2012